A Dyslipidemia Refresher


Manage episode 272097942 series 1947483
By CorConsult Rx, Mike Corvino, BCPS, BCACP, CDCES, and Cole Swanson. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

On this episode, we revisit the management of of dyslipidemia. We review the basic pathophysiology of atherosclerosis and the four statin treatment groups. We also discuss where ezetimibe and PCSK9 inhibitors fit into the treatment regimens. We close with an overview of the EVAPORATE trial with icosapent ethyl (Vascepa) and the bempedoic acid (Nexletol) CVOT called CLEAR Outcomes.

Thanks for listening!

If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable Power Point slides for each lecture. You can find our account at the website below:


If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

144 episodes